1. 1291. PROVE (Retrospective Cefiderocol Chart Review) Study of Real-World Outcomes and Safety in the Treatment of Patients with Gram-negative Bacterial Infections in the US and Europe. (4th December 2021) Authors: Marcella, Stephen; Chopra, Teena; Chopra, Teena; Vazquez, Jose A; Smoke, Steven; Shields, Ryan K; van Duin, David Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1291. PROVE (Retrospective Cefiderocol Chart Review) Study of Real-World Outcomes and Safety in the Treatment of Patients with Gram-negative Bacterial Infections in the US and Europe. (4th December 2021) Authors: Marcella, Stephen; Chopra, Teena; Chopra, Teena; Vazquez, Jose A; Smoke, Steven; Shields, Ryan K; van Duin, David Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1306. Real-World Experience of Cefiderocol in Treating Bacterial Infection in US Hospitals (Jan 2020-June 2021). (15th December 2022) Authors: Cai, Bin; Zhou, Yun; Cooper, Andrew; Marcella, Stephen Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 501. Evaluation of Bezlotoxumab in Prevention of Recurrent C. difficile Infection: A Multicenter Single-Arm Study in Outpatient Infusion Centers. (26th November 2018) Authors: Hengel, Richard L; Ritter, Timothy E; Nathan, Ramesh V; Van Anglen, Lucinda J; Schroeder, Claudia P; Marcella, Stephen; Garey, Kevin W Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 666. Outcomes Using Cefiderocol for the Treatment of Acinetobacter baumannii Infections from the PROVE (Real-World Evidence) Study. (15th December 2022) Authors: Marcella, Stephen; Kobic, Emir; Carr, Amy L; Georgiades, Benjamin; Margiotta, Caroline Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 667. Real-world Experience of Cefiderocol with Pseudomonas aeruginosa in the PROVE (Retrospective Cefiderocol Chart Review) Study. (15th December 2022) Authors: Marcella, Stephen; Carr, Amy L; Kobic, Emir; Nguyen, Sean; Zhou, Anan Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 762Outpatient Parenteral Antimicrobial Therapy (OPAT) Treatment Center as Part of Integrated Care Delivery – Single-Center Experience from the First Three Years of Operation. (December 2014) Authors: Bochan, Markian; Sung, Anita; Elizondo, Deidre; Lock, John; Marcella, Stephen; Xie, Yang Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 833. Characteristics and Utilization Patterns of Colistin Compared with Newer Agents in Gram-Negative Infections. (31st December 2020) Authors: Marcella, Stephen; Doremus, Casey; Echols, Roger Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 848. Trends of Carbapenem Resistance in Enterobacterales in the US Between 2015 and 2019. (31st December 2020) Authors: Marcella, Stephen; Kanakamedala, Hemanth; Zhou, Yun; Cai, Bin; Pogue, Jason M Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials. (15th November 2018) Authors: Basu, Anirban; Prabhu, Vimalanand S; Dorr, Mary Beth; Golan, Yoav; Dubberke, Erik R; Cornely, Oliver A; Heimann, Sebastian M; Pedley, Alison; Xu, Ruifeng; Hanson, Mary E; Marcella, Stephen Journal: Open forum infectious diseases Issue: Volume 5:Number 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗